Owner University of Rochester Vaccinex, Inc.

Inventors Zauderer, Maurice; Borrello, Melinda A.; Evans, Elizabeth E.

Agent Callinan

Pub. Number AU-B-2003274463

PCT Number PCT/US03/18252

PCT Pub. Number WO2003/104428

Priority 60/432,241 11.12.02 US; 60/386,738 10.06.02 US; 60/464,650 23.04.03 US

Filing date 10 June 2003

Wipo publication date 22 December 2003

Acceptance publication date 29 October 2009

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells